(Total Views: 405)
Posted On: 07/22/2019 10:53:58 AM
Post# of 72446
Re: someconcerns #58426
Quote:
has executed a license agreement with Alfasigma
About Alfasigma
Alfasigma is a privately-owned, Italy-based integrated multinational pharmaceutical company with 2018 revenues in excess of €1 billion, 5 manufacturing plants, R&D facilities, and 3,000 employees globally. Outside of its core Italian market, Alfasigma has 16 subsidiaries in Europe, Asia, North and Central America and Africa, and is present in more than 90 countries. More than 44% of Alfasigma turnover comes from internally developed proprietary products, one of which is XIFAXAN. More information is available at the Alfasigma website at: http://www.alfasigma.com/en
very nice news .. thx for posting ..
4kids
(4)
(0)
